Abdulrahman A Alhajahjeh (Abdulrahman Alhajahjeh)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 7

Top Topics

Ankylosing Spondylitis

Systematic Review

Cross Sectional

Top Venues

JCO global oncology

Breast cancer (Dove Medical Press)

Orthopedic research and reviews

This page only lists publications with an associated author ORCID identifier.

Publications

Abdulrahman A Alhajahjeh, Ra'ad Al-Faouri, Hisham F Bahmad, Taima' Bader, Ryan W Dobbs, Ahmed A Abdulelah, Wassim Abou Kheir, Elai Davicioni, David I Lee, Mohammed Shahait
From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist's Dual Role in Prostate Cancer. Cancers 16 (8) (2024)
Abdulrahman A Alhajahjeh, Majedah Hmeidan, Mus'ab Elatrsh, Faris Al-Abbadi, Diala Kakish, Razan Sukerji, Mohammad Salah, Bashir Al Hussein Al Awamlh, David I Lee, Mohammed Shahait
Understanding the Termination of Urologic Cancer Clinical Trials: Insights and Challenges. JCO global oncology 10 (2024)
Abdulrahman A Alhajahjeh, Majedah Hmeidan, Mus'ab Elatrsh, Faris Al-Abbadi, Diala Kakish, Razan Sukerji, Mohammad Salah, Bashir Al Hussein Al Awamlh, David I Lee, Mohammed Shahait
Understanding the Termination of Urologic Cancer Clinical Trials: Insights and Challenges. JCO global oncology 10 (2024)
Abdulrahman A Alhajahjeh, Ra'ad Al-Faouri, Hisham F Bahmad, Taima' Bader, Ryan W Dobbs, Ahmed A Abdulelah, Wassim Abou Kheir, Elai Davicioni, David I Lee, Mohammed Shahait
From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist's Dual Role in Prostate Cancer. Cancers 16 (8) (2024)
Abdulrahman A Alhajahjeh, Majedah Hmeidan, Mus'ab Elatrsh, Faris Al-Abbadi, Diala Kakish, Razan Sukerji, Mohammad Salah, Bashir Al Hussein Al Awamlh, David I Lee, Mohammed Shahait
Understanding the Termination of Urologic Cancer Clinical Trials: Insights and Challenges. JCO global oncology 10 (2024)
Baha' Sharaf, Hala Abu-Fares, Faris Tamimi, Suhaib Al-Sawajneh, Osama Salama, Rand Daoud, Abdulrahman A Alhajahjeh, Sawsan Al-Lababidi, Hikmat Abdel-Razeq
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib. Breast cancer (Dove Medical Press) 15 (2023)
Ahmed A Abdulelah, Bassem I Haddad, Abdulrahman A Alhajahjeh, Lina M AlQirem, Layla El-Amayreh
The Risk of Developing Osteosarcoma After Teriparatide Use: A Systematic Review. Orthopedic research and reviews 15 (2023)